Breastfeeding News and Research

Latest Breastfeeding News and Research

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced that Synjardy (empagliflozin/metformin hydrochloride) tablets are now available by prescription in pharmacies across the United States.

14 Oct 2015

Study: Women less likely than men to have good relief of chronic pain with long-term opioid use

Women, and especially younger women, are much less likely than men to have good relief of chronic, non-cancer pain with long-term opioid use, with only one in five women reporting low levels of pain and high levels of function with chronic opioid therapy in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

9 Oct 2015

FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC

The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.

9 Oct 2015

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.

1 Oct 2015

Women’s life expectancy in eastern and western Germany continues to increase, shows study

Twenty-five years after reunification, the once considerable differences between life expectancy in eastern and western Germany have almost disappeared for women.

23 Sep 2015

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

22 Sep 2015

UN reports that more needs to be done so all children are born HIV and syphilis free in Asia-Pacific region

The Asia–Pacific region has made significant progress in efforts to eliminate HIV and syphilis, but thousands of mothers and children have yet to feel the benefits.

14 Sep 2015

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Nurse-trainer Helena Cumbelembe Inacio was struggling to teach nurses at the health center here the correct combination of medicines to prevent pregnant women with HIV from passing the infection to their children.

11 Sep 2015

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.

11 Sep 2015

Study finds increased rates of breast cancer incidence, mortality in low and middle income countries

A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.

10 Sep 2015

Exclusive breastfeeding should be supported in women with MS

Exclusive breastfeeding appears to have a protective effect against the return of disease activity after pregnancy in women with multiple sclerosis, say researchers.

9 Sep 2015

Report highlights remarkable decline in child mortality, but MDG target still missed by wide margin

Child mortality rates have plummeted to less than half of what they were in 1990, according to a new report released today. Under-five deaths have dropped from 12.7 million per year in 1990 to 5.9 million in 2015. This is the first year the figure has gone below the 6 million mark.

9 Sep 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

1 Sep 2015

ESC publishes new guidelines on pericardial diseases

New ESC Guidelines on pericardial diseases are published today. Until now there was insufficient evidence for strong recommendations in this group of conditions which can severely restrict quality of life.

29 Aug 2015

Tampa General Hospital achieves Baby-Friendly hospital designation

Tampa General Hospital is the first hospital in Hillsborough County – and one of only three in the Tampa Bay area – to earn the Baby-Friendly hospital designation from Baby-Friendly USA, Inc. for its commitment to supporting breastfeeding mothers and their babies.

28 Aug 2015

Proper iodine nutrition necessary during pregnancy

New research published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, found that pregnant women in Sweden had inadequate levels of iodine in their diets. Proper iodine nutrition is necessary for neurological development of the fetus.

27 Aug 2015

Findings highlight significance of optimal breastfeeding practices during infancy, early childhood

In a new review of all relevant medical research on breastfeeding practices, infants 0 to 5 months of age who were predominantly, partially, or not breastfed had 1.5-, 4.8-, and 14.4-times higher risks of dying, respectively, compared with exclusively breastfed infants.

26 Aug 2015

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.

25 Aug 2015

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.

20 Aug 2015

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardiance (empagliflozin) in more than 7,000 adults with type 2 diabetes (T2D) at high risk for CV events.

20 Aug 2015

Breastfeeding News and Research

Latest Breastfeeding News and Research

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Study: Women less likely than men to have good relief of chronic pain with long-term opioid use

FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Women’s life expectancy in eastern and western Germany continues to increase, shows study

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

UN reports that more needs to be done so all children are born HIV and syphilis free in Asia-Pacific region

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

Study finds increased rates of breast cancer incidence, mortality in low and middle income countries

Exclusive breastfeeding should be supported in women with MS

Report highlights remarkable decline in child mortality, but MDG target still missed by wide margin

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

ESC publishes new guidelines on pericardial diseases

Tampa General Hospital achieves Baby-Friendly hospital designation

Proper iodine nutrition necessary during pregnancy

Findings highlight significance of optimal breastfeeding practices during infancy, early childhood

Shire enters into agreement with Sanquin for CINRYZE

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Breastfeeding News and Research

Latest Breastfeeding News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in